Delivery Order SPE2DB20D3505-SPE2DB25FU3J3

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,775.10, is for the delivery of 4,566,526,169 tablets of Risperidone 0.25 mg. It is a firm fixed-price delivery order contract with a completion date of November 25, 2024. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,968.22, is for the delivery of Risperidone 0.25 mg tablets in 500-count bottles. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $5,141.34 for the supply of risperidone 0.5 mg tablets. The contract has an ultimate completion date of March 12, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $2,508.01 firm fixed-price delivery order is for the supply of 500 tablets of 0.25 mg risperidone, a medication used to treat mental health conditions. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Risperidone 0.5 mg tablets. The $3,253.35 firm fixed-price delivery order has a completion date of June 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a prime vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,190.76, is for the delivery of 4566343159 - Risperidone 0.5 mg Tablets, 60 count, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a final completion date of November 6, 2024. The award is not associated with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Risperidone 2 mg tablets. The $5,809.24 firm fixed-price contract has a completion date of November 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,368.11 firm fixed-price delivery order is for the supply of 500 units of the drug Risperidone 0.25 mg tablet. The award is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,306.05, is for the delivery of 500 packages of Risperidone 0.25 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 19, 2023 and is a firm fixed-price contract. No set-aside designation was used for this award....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,920.07, is for the delivery of 4563239012 Risperidone 2 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FU3J3
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of risperidone 0.25 mg tablets. The contract, valued at $1,514.21, is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is part of that larger IDC and does not have a set-aside designation, indicating open competition.

Generated 7/4/25, 11:33 AM